Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
Esperion Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 16, 2020
Esperion Therapeutics reported fiscal year 2019 executive compensation information on April 16, 2020.
In 2019, three executives at Esperion Therapeutics received on average a compensation package of $730K, a 88% decrease compared to previous year.
Average pay of disclosed executives at Esperion Therapeutics
Tim M. Mayleben, Chief Executive Officer, received $1.1M in total, which decreased by 89% compared to 2018. 58% of Mayleben's compensation, or $625K, was in salary. Mayleben also received $375K in non-equity incentive plan and $81K in other compensation.
For fiscal year 2019, the median employee pay was $242,988 at Esperion Therapeutics. Therefore, the ratio of Tim M. Mayleben's pay to the median employee pay was 4 to one.
Mark. A Glickman, Chief Commercial Officer, received a compensation package of $624K, which decreased by 93% compared to previous year. 70% of the compensation package, or $440K, was in salary.
Richard B. Bartram, Chief Financial Officer, earned $486K in 2019, a 81% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 16, 2020.